| 1. |
Use of stimulants in children with ADHD debated |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Access to the best treatment is required when a trial ends, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Ramipril cost effective in patients at high risk for cardiovascular events |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
The cost of improving outcomes in COPD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 5-6
&NA;,
Preview
|
|
摘要:
Chronic obstructive pulmonary disease (COPD) is a prevalent condition that is associated with greatly diminished QOL, increased use of healthcare resources, and hospitalisation costs related to acute exacerbations. Drug treatments which can improve patients' QOL, reduce the rate of exacerbations, and consequently healthcare resource use and costs, are of much importance worldwide. Inhaled corticosteroids, tiotropium bromide, cilomilast and salmeterol/fluticasone propionate are all useful drugs for this disease. The effect of these drugs on certain outcomes in COPD patients were assessed by various researchers and presented at the 14th Annual Congress of the European Respiratory Society [Glasgow, Scotland; Sep 2004]
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Escitalopram lowest risk of ADRs = lowest cost in depression |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Analgesia requirements for women undergoing medical abortion differ according to certain characteristics, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
RTS,S/AS02A vaccine: beginning of the end forP. falciparum? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Prasugrel a promising antiplatelet agent for angioplasty |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 9-10
S Sullivan,,
Preview
|
|
摘要:
Prasugrel [CS 747] is as effective as clopidogrel in reducing the incidence of cardiovascular events in patients who have undergone percutaneous coronary intervention (PCI), according to the results of the JUMBO-TIMI 26 study presented at the 26th Annual Congress of the European Society of Cardiology (ESC) [Munich, Germany; August-September 2004]. Patients receiving prasugrel experienced fewer major adverse cardiac events at 30 days than clopidogrel recipients. Furthermore, prasugrel was well tolerated, with a similar incidence of bleeding episodes observed in the prasugrel and clopidogrel groups.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
CDP 571 only short-term efficacy in Crohn's disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Ibuprofen does not provide additional benefit to cyclobenzaprine in patients with acute pain and muscle spasm of the back and neck, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1460,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
